79 related articles for article (PubMed ID: 19372777)
1. Acute HIV infection: it takes more than guts.
Mattapallil JJ; Roederer M
Curr Opin HIV AIDS; 2006 Jan; 1(1):10-5. PubMed ID: 19372777
[TBL] [Abstract][Full Text] [Related]
2. HIV vaccines: can mucosal CD4 T cells be protected?
Mattapallil JJ; Roederer M
Curr Opin HIV AIDS; 2006 Jul; 1(4):272-6. PubMed ID: 19372821
[TBL] [Abstract][Full Text] [Related]
3. Treatment interruption to boost specific HIV immunity in acute infection.
Kaufmann DE; Walker BD
Curr Opin HIV AIDS; 2007 Jan; 2(1):21-5. PubMed ID: 19372861
[TBL] [Abstract][Full Text] [Related]
4. Innate gamma/delta T-cells during HIV infection: Terra relatively Incognita in novel vaccination strategies?
Agrati C; D'Offizi G; Gougeon ML; Malkovsky M; Sacchi A; Casetti R; Bordoni V; Cimini E; Martini F
AIDS Rev; 2011; 13(1):3-12. PubMed ID: 21412385
[TBL] [Abstract][Full Text] [Related]
5. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
6. T-cell responses in primary HIV-1 infection.
Streeck H; van Bockel D; Kelleher A
Curr Opin HIV AIDS; 2008 Jan; 3(1):52-9. PubMed ID: 19372944
[TBL] [Abstract][Full Text] [Related]
7. Disrupting T-cell homeostasis: how HIV-1 infection causes disease.
Douek DC
AIDS Rev; 2003; 5(3):172-7. PubMed ID: 14598566
[TBL] [Abstract][Full Text] [Related]
8. HIV infection and rheumatic diseases--autoimmune mechanisms in immunodeficient hosts.
Weyand CM; Goronzy JJ
Z Rheumatol; 1992; 51(2):55-64. PubMed ID: 1535472
[TBL] [Abstract][Full Text] [Related]
9. New paradigms for generating effective CD8+ T cell responses against HIV-1/AIDS.
Ahlers JD; Belyakov IM
Discov Med; 2010 Jun; 9(49):528-37. PubMed ID: 20587342
[TBL] [Abstract][Full Text] [Related]
10. Mucosal immune dysfunction in AIDS pathogenesis.
Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
[TBL] [Abstract][Full Text] [Related]
11. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
12. [CD4 lymphocytes as targets and actors in the pathogenesis of HIV infection--therapeutic implications].
Theze J
Bull Acad Natl Med; 2008 Oct; 192(7):1453-66; discussion 1466-8. PubMed ID: 19445368
[TBL] [Abstract][Full Text] [Related]
13. Viral reservoirs and HIV-specific immunity.
Blankson JN
Curr Opin HIV AIDS; 2006 Mar; 1(2):147-51. PubMed ID: 19372799
[TBL] [Abstract][Full Text] [Related]
14. Viral and host factors in the pathogenesis of HIV infection.
Derdeyn CA; Silvestri G
Curr Opin Immunol; 2005 Aug; 17(4):366-73. PubMed ID: 15955686
[TBL] [Abstract][Full Text] [Related]
15. Th17 cells, HIV and the gut mucosal barrier.
Dandekar S; George MD; Bäumler AJ
Curr Opin HIV AIDS; 2010 Mar; 5(2):173-8. PubMed ID: 20543596
[TBL] [Abstract][Full Text] [Related]
16. Treatment of acute HIV-1 infection: are we getting there?
Cellerai C; Little SJ; Loes SK
Curr Opin HIV AIDS; 2008 Jan; 3(1):67-74. PubMed ID: 19372946
[TBL] [Abstract][Full Text] [Related]
17. Role of HIV-1-specific CD4 T cells.
Harari A; Cellerai C; Pantaleo G
Curr Opin HIV AIDS; 2006 Jan; 1(1):22-7. PubMed ID: 19372779
[TBL] [Abstract][Full Text] [Related]
18. Probing the possibilities for T-cell-based AIDS vaccines.
Garber DA; Feinberg MB
Curr Opin HIV AIDS; 2006 Jul; 1(4):314-22. PubMed ID: 19372827
[TBL] [Abstract][Full Text] [Related]
19. Neurological disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.
Wright EJ
Curr Opin HIV AIDS; 2009 Sep; 4(5):447-52. PubMed ID: 20048710
[TBL] [Abstract][Full Text] [Related]
20. The promise and challenge of anti-HIV cellular immunity.
Borrow P; Turnbull EL
Curr Opin HIV AIDS; 2006 Jul; 1(4):277-85. PubMed ID: 19372822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
